布地奈德联合硫酸沙丁胺醇雾化吸入治疗小儿哮喘疗效观察

Efficacy of Budesonide Combined With Salbutamol Sulfate Aerosol Inhalation Therapy in the Treatment of Infantile Asthma

目的:观察布地奈德联合硫酸沙丁胺醇雾化吸入治疗小儿哮喘的疗效。方法:选取2018年8月~2019年2月在某院治疗小儿哮喘的102例患儿,分为观察组和对照组,观察组患者选择布地奈德联合硫酸沙丁胺醇雾化吸入的治疗方式,对照组患者则只选择雾化吸入布地奈德。经过治疗干预后比较两组患儿的临床有效率,并比较两组患儿喘息、哮鸣音、咳嗽、呼吸困难等临床症状消失的时间。结果:经过治疗干预,观察组患者的临床有效率为88.23%,高于对照组患者68.62%的临床有效率;喘息、呼吸困难、哮鸣音、咳嗽等临床症状消失的时间早于对照组。结论:采取布地奈德联合硫酸沙丁胺醇雾化吸入的治疗方式可以提高患儿的临床有效率,且患儿临床症状消失较快,有利于减轻患儿的痛苦。

Objective: To observe the therapeutic effect of budesonide combined with salbutamol sulfate aerosol inhalation therapy in the treatment of infantile asthma. Methods: A total of 102 children with asthma treated in a hospital from August 2018 to February 2019 were selected and divided into observation group and control group. Patients in the observation group were selected to receive budesonide combined with salbutamol sulfate atomization inhalation, while patients in the control group were selected to receive budesonide atomization inhalation. After treatment intervention, the clinical efficiency of the two groups of children was compared, and the time of disappearance of symptoms such as wheezing, wheezing, cough and dyspnea was compared. Results: After treatment intervention, the clinical response rate of the observation group was 88.23%, higher than that of the control group with 68.62%. Wheezing, dyspnea, asthma, cough and other clinical symptoms disappeared earlier than the control group. Conclusion: Budesonide combined with salbutamol sulfate aerosol inhalation can improve the clinical efficiency of children, and the clinical symptoms disappear quickly, which is beneficial to relieve the pain of children.